# Dropbox, Inc.: financial statements, quarterly

DBX · Nasdaq · CIK 1467623 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dbx.md) · [Financials](/companies/dbx/financials.md) · [Filings](/companies/dbx/filings.md) · [Insiders](/companies/dbx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dbx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [633](/filings/0001467623-24-000051.md) | [635 d](/filings/0001467623-26-000008.md) | [631](/filings/0001467623-25-000060.md) | [635](/filings/0001467623-25-000117.md) | [639](/filings/0001467623-25-000129.md) | [644 d](/filings/0001467623-26-000008.md) | [625](/filings/0001467623-26-000031.md) | [626](/filings/0001467623-26-000049.md) | [634](/filings/0001467623-25-000129.md) | [636 d](/filings/0001467623-26-000008.md) | [630](/filings/0001467623-26-000031.md) | [632](/filings/0001467623-26-000049.md) |
| Cost of revenue | $m | [120](/filings/0001467623-24-000051.md) | [122 d](/filings/0001467623-26-000008.md) | [106](/filings/0001467623-25-000060.md) | [107](/filings/0001467623-25-000117.md) | [112](/filings/0001467623-25-000129.md) | [121 d](/filings/0001467623-26-000008.md) | [117](/filings/0001467623-26-000031.md) | [124](/filings/0001467623-26-000049.md) | [128](/filings/0001467623-25-000129.md) | [132 d](/filings/0001467623-26-000008.md) | [128](/filings/0001467623-26-000031.md) | [125](/filings/0001467623-26-000049.md) |
| Gross profit | $m | [513](/filings/0001467623-24-000051.md) | [513 d](/filings/0001467623-26-000008.md) | [526](/filings/0001467623-25-000060.md) | [528](/filings/0001467623-25-000117.md) | [527](/filings/0001467623-25-000129.md) | [523 d](/filings/0001467623-26-000008.md) | [508](/filings/0001467623-26-000031.md) | [502](/filings/0001467623-26-000049.md) | [506](/filings/0001467623-25-000129.md) | [504 d](/filings/0001467623-26-000008.md) | [501](/filings/0001467623-26-000031.md) | [507](/filings/0001467623-26-000049.md) |
| Research and development | $m | [216](/filings/0001467623-24-000051.md) | [222 d](/filings/0001467623-26-000008.md) | [219](/filings/0001467623-25-000060.md) | [227](/filings/0001467623-25-000117.md) | [226](/filings/0001467623-25-000129.md) | [243 d](/filings/0001467623-26-000008.md) | [178](/filings/0001467623-26-000031.md) | [184](/filings/0001467623-26-000049.md) | [182](/filings/0001467623-25-000129.md) | [187 d](/filings/0001467623-26-000008.md) | [184](/filings/0001467623-26-000031.md) | [188](/filings/0001467623-26-000049.md) |
| Operating income | $m | [131](/filings/0001467623-24-000051.md) | [267 d](/filings/0001467623-26-000008.md) | [144](/filings/0001467623-25-000060.md) | [127](/filings/0001467623-25-000117.md) | [128](/filings/0001467623-25-000129.md) | [87.9 d](/filings/0001467623-26-000008.md) | [184](/filings/0001467623-26-000031.md) | [168](/filings/0001467623-26-000049.md) | [175](/filings/0001467623-25-000129.md) | [162 d](/filings/0001467623-26-000008.md) | [173](/filings/0001467623-26-000031.md) | [165](/filings/0001467623-26-000049.md) |
| Income tax | $m | [21.4](/filings/0001467623-24-000051.md) | [45.0 d](/filings/0001467623-26-000008.md) | [18.8](/filings/0001467623-25-000060.md) | [23.1](/filings/0001467623-25-000117.md) | [26.0](/filings/0001467623-25-000129.md) | [(10.4) d](/filings/0001467623-26-000008.md) | [19.2](/filings/0001467623-26-000031.md) | [22.2](/filings/0001467623-26-000049.md) | [33.4](/filings/0001467623-25-000129.md) | [34.4 d](/filings/0001467623-26-000008.md) | [26.9](/filings/0001467623-26-000031.md) | [21.9](/filings/0001467623-26-000049.md) |
| Net income | $m | [114](/filings/0001467623-24-000051.md) | [227 d](/filings/0001467623-26-000008.md) | [132](/filings/0001467623-25-000060.md) | [111](/filings/0001467623-25-000117.md) | [107](/filings/0001467623-25-000129.md) | [103 d](/filings/0001467623-26-000008.md) | [150](/filings/0001467623-26-000031.md) | [126](/filings/0001467623-26-000049.md) | [124](/filings/0001467623-25-000129.md) | [109 d](/filings/0001467623-26-000008.md) | [115](/filings/0001467623-26-000031.md) | [95.8](/filings/0001467623-26-000049.md) |
| Diluted EPS | $ per share | [0.33](/filings/0001467623-24-000051.md) | not reported | [0.39](/filings/0001467623-25-000060.md) | [0.34](/filings/0001467623-25-000117.md) | [0.34](/filings/0001467623-25-000129.md) | not reported | [0.51](/filings/0001467623-26-000031.md) | [0.45](/filings/0001467623-26-000049.md) | [0.47](/filings/0001467623-25-000129.md) | not reported | [0.48](/filings/0001467623-26-000031.md) | [0.42](/filings/0001467623-26-000049.md) |
| Basic EPS | $ per share | [0.34](/filings/0001467623-24-000051.md) | not reported | [0.40](/filings/0001467623-25-000060.md) | [0.34](/filings/0001467623-25-000117.md) | [0.34](/filings/0001467623-25-000129.md) | not reported | [0.52](/filings/0001467623-26-000031.md) | [0.46](/filings/0001467623-26-000049.md) | [0.47](/filings/0001467623-25-000129.md) | not reported | [0.49](/filings/0001467623-26-000031.md) | [0.43](/filings/0001467623-26-000049.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [604](/filings/0001467623-23-000051.md) | [615](/filings/0001467623-26-000008.md) | [549](/filings/0001467623-25-000060.md) | [515](/filings/0001467623-25-000117.md) | [518](/filings/0001467623-25-000129.md) | [1,328](/filings/0001467623-26-000008.md) | [942](/filings/0001467623-26-000031.md) | [736](/filings/0001467623-26-000049.md) | [731](/filings/0001467623-25-000129.md) | [891](/filings/0001467623-26-000049.md) | [1,207](/filings/0001467623-26-000031.md) | [1,056](/filings/0001467623-26-000049.md) |
| Current assets | $m | [1,467](/filings/0001467623-23-000051.md) | [1,517](/filings/0001467623-25-000011.md) | [1,339](/filings/0001467623-24-000030.md) | [1,231](/filings/0001467623-24-000041.md) | [1,046](/filings/0001467623-24-000051.md) | [1,738](/filings/0001467623-26-000008.md) | [1,335](/filings/0001467623-25-000060.md) | [1,114](/filings/0001467623-25-000117.md) | [1,083](/filings/0001467623-25-000129.md) | [1,191](/filings/0001467623-26-000049.md) | [1,448](/filings/0001467623-26-000031.md) | [1,266](/filings/0001467623-26-000049.md) |
| Total assets | $m | [3,011](/filings/0001467623-23-000051.md) | [2,984](/filings/0001467623-25-000011.md) | [2,798](/filings/0001467623-24-000030.md) | [2,719](/filings/0001467623-24-000041.md) | [2,577](/filings/0001467623-24-000051.md) | [3,325](/filings/0001467623-26-000008.md) | [2,957](/filings/0001467623-25-000060.md) | [2,779](/filings/0001467623-25-000117.md) | [2,796](/filings/0001467623-25-000129.md) | [2,845](/filings/0001467623-26-000049.md) | [3,031](/filings/0001467623-26-000031.md) | [2,826](/filings/0001467623-26-000049.md) |
| Current liabilities | $m | [1,197](/filings/0001467623-23-000051.md) | [1,202](/filings/0001467623-25-000011.md) | [1,167](/filings/0001467623-24-000030.md) | [1,184](/filings/0001467623-24-000041.md) | [1,202](/filings/0001467623-24-000051.md) | [1,211](/filings/0001467623-26-000008.md) | [1,837](/filings/0001467623-25-000060.md) | [1,855](/filings/0001467623-25-000117.md) | [1,903](/filings/0001467623-25-000129.md) | [1,894](/filings/0001467623-26-000049.md) | [1,176](/filings/0001467623-26-000031.md) | [1,179](/filings/0001467623-26-000049.md) |
| Total liabilities | $m | [3,361](/filings/0001467623-23-000051.md) | [3,149](/filings/0001467623-25-000011.md) | [3,075](/filings/0001467623-24-000030.md) | [3,090](/filings/0001467623-24-000041.md) | [3,123](/filings/0001467623-24-000051.md) | [4,078](/filings/0001467623-26-000008.md) | [4,033](/filings/0001467623-25-000060.md) | [4,085](/filings/0001467623-25-000117.md) | [4,327](/filings/0001467623-25-000129.md) | [4,642](/filings/0001467623-26-000049.md) | [5,043](/filings/0001467623-26-000031.md) | [5,015](/filings/0001467623-26-000049.md) |
| Shareholders' equity | $m | [(350)](/filings/0001467623-24-000051.md) | [(166)](/filings/0001467623-26-000008.md) | [(277)](/filings/0001467623-25-000117.md) | [(371)](/filings/0001467623-25-000129.md) | [(546)](/filings/0001467623-25-000129.md) | [(752)](/filings/0001467623-26-000049.md) | [(1,076)](/filings/0001467623-26-000049.md) | [(1,306)](/filings/0001467623-26-000049.md) | [(1,531)](/filings/0001467623-25-000129.md) | [(1,797)](/filings/0001467623-26-000049.md) | [(2,012)](/filings/0001467623-26-000049.md) | [(2,188)](/filings/0001467623-26-000049.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [256 d](/filings/0001467623-24-000051.md) | [200 d](/filings/0001467623-26-000008.md) | [176](/filings/0001467623-25-000060.md) | [231 d](/filings/0001467623-25-000117.md) | [274 d](/filings/0001467623-25-000129.md) | [214 d](/filings/0001467623-26-000008.md) | [154](/filings/0001467623-26-000031.md) | [261 d](/filings/0001467623-26-000049.md) | [302 d](/filings/0001467623-25-000129.md) | [235 d](/filings/0001467623-26-000008.md) | [205](/filings/0001467623-26-000031.md) | [239 d](/filings/0001467623-26-000049.md) |
| Capital expenditure | $m | [9.4 d](/filings/0001467623-24-000051.md) | [10.0 d](/filings/0001467623-26-000008.md) | [9.2](/filings/0001467623-25-000060.md) | [5.9 d](/filings/0001467623-25-000117.md) | [4.1 d](/filings/0001467623-25-000129.md) | [3.3 d](/filings/0001467623-26-000008.md) | [0.1](/filings/0001467623-26-000031.md) | [2.0 d](/filings/0001467623-26-000049.md) | [8.4 d](/filings/0001467623-25-000129.md) | [10.5 d](/filings/0001467623-26-000008.md) | [1.2](/filings/0001467623-26-000031.md) | [3.3 d](/filings/0001467623-26-000049.md) |
| Share repurchases | $m | [104 d](/filings/0001467623-24-000051.md) | [106 d](/filings/0001467623-26-000008.md) | [279](/filings/0001467623-25-000060.md) | [260 d](/filings/0001467623-25-000117.md) | [349 d](/filings/0001467623-25-000129.md) | [353 d](/filings/0001467623-26-000008.md) | [499](/filings/0001467623-26-000031.md) | [410 d](/filings/0001467623-26-000049.md) | [390 d](/filings/0001467623-25-000129.md) | [415 d](/filings/0001467623-26-000008.md) | [367](/filings/0001467623-26-000031.md) | [330 d](/filings/0001467623-26-000049.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [360](/filings/0001467623-23-000051.md) | [349](/filings/0001467623-24-000030.md) | [344](/filings/0001467623-24-000041.md) | [346](/filings/0001467623-24-000051.md) | [341](/filings/0001467623-25-000060.md) | [324](/filings/0001467623-25-000117.md) | [316](/filings/0001467623-25-000129.md) | [296](/filings/0001467623-26-000031.md) | [277](/filings/0001467623-26-000049.md) | [265](/filings/0001467623-25-000129.md) | [237](/filings/0001467623-26-000031.md) | [227](/filings/0001467623-26-000049.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.